Revvity, Inc. (RVTY) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Waltham, MA, United States. The current CEO is Prahlad R. Singh.
RVTY has IPO date of 1965-07-06, 11,000 full-time employees, listed on the NYSE, a market capitalization of $10.45B.
Revvity, Inc. is a global provider of products, services, and solutions serving the diagnostics, life sciences, and applied services markets. Operating through two primary segments, Discovery & Analytical Solutions and Diagnostics, the company offers a comprehensive portfolio including analytical instruments, reagents, software, and imaging technologies for research and industrial applications across pharmaceuticals, environmental monitoring, food production, and chemical analysis. The Diagnostics segment specializes in instruments and assay platforms for genetic disorder detection, infectious disease testing, and genomic workflows, serving pharmaceutical companies, biotechnology firms, laboratories, academic institutions, and healthcare organizations worldwide. Founded in 1937 and headquartered in Waltham, Massachusetts, Revvity rebranded from PerkinElmer, Inc. in April 2023 to reflect its evolved market positioning and capabilities.
